1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Licensing Program Analyst (LPA) Hansen conducted an unannounced case management inspection, while delivering complaint findings, and met with General Manager Rabah Sbaitan. The purpose of this case management is to follow up on five self reported incident reports submitted to Community Care Licensing (CCL). Two on 12/22/2023 and one on 12/28/2023, 1/29/2024, 2/1/2024, & 2/8/2024.
CCL received a self reported incident report reporting on 12/14/2023 night medication technician (Med-tech) notified nurse resident (R1) had frequent urination. Review of R1’s medication records revealed R1 had not received Tamsulosin medication since 11/26/2023 due to pharmacy unable to renew prescription as incorrect doctor was listed. Primary Care Physician’s (PCP) office notified, and emergency supplies of medication were delivered and given to R1 on 12/15/2023.
LPA obtained additional information regarding a medication error that occurred on 12/14/2023 involving R2. On 12/13/23 delivery of Midodrine was assigned to Med Tech instead of nurse, which was given at 8 am, then another dose was given at 9:40am by nurse without checking Emar. R2 assessed with no adverse effects noted. All required parties notified. In-service training provided & LPA obtained copy.
LPA followed up on an incident submitted to CCL on 1/16/2024 for a medication error that occurred on 12/28/2023. On 12/29/2023 AM Medication manager found cup with R3’s PM medications. Nurse assessed R3 with no adverse effects. LPA obtained internal investigation, disciplinary action, & In-service training. LPA is providing LIC 9102 TA for reporting incident to CCL later then Title 22 regulations of 7 days.
CCL received a self reported incident report on 1/29/2024 of a medication error that occurred on 1/17/2024. R3 had received two 5mg tablets of their amlodipine instead of one as staff opened a new bubble pack of mediation prior to finishing the current supply. There were no adverse effects shown and all required parties notified. Continue on LIC809-C
|